Health Care

Pfizer is reporting a second-quarter profit surge, though the drugmaker says weakening currencies in Europe and Asia could nick revenue ahead.

The Environmental Protection Agency is announcing the recall of a half-million trucks with faulty pollution controls.

The U.S. drugmaker said net income rose to $3.87 billion.

Sen. Bernie Sanders' "Medicare for all" plan would increase government health care spending by $32.6 trillion over 10 years, according to a study by a university-based libertarian policy center.

Merck & Co.is reporting a strong second quarter with global sales rising 5 percent to $10.5 billion.

State officials and death penalty experts say a court-ordered delay of Nevada's first execution in 12 years could have a ripple effect in some of the other 30 U.S. states with capital punishment.

Bristol-Myers Squibb Co. (BMY) on Thursday reported second-quarter earnings of $373 million.

German automaker Daimler AG says its net profit fell 27 percent in the second quarter to 1.8 billion euros, from 2.5 billion euros a year earlier.

Anglo-Swedish drugmaker AstraZeneca says second-quarter earnings dropped 27 percent as it shifted away from dependence on its former blockbuster drugs and toward new cancer drugs.

The treatment inventor says the opioid crisis is growing at a rapid pace.

The Trump administration's Medicare chief is slamming "Medicare for All," the proposal from Vermont Sen. Bernie Sanders for a national health care plan that would cover all Americans.

The latest on developments in financial markets (all times local): 9:35 a.m.

America's healthcare industry is beginning to shift its focus from treating to preventative plans.

Uber officials say the company has taken the first step toward relaunching its self-driving cars on Pittsburgh-area streets four months after a fatal accident involving one of the cars in Arizona.

A consumer rights group has filed a complaint alleging a Minneapolis health care provider ignored ethical practices and federal safeguards when it researched the effect of the powerful sedative ketamine on more than 100 participants without their prior consent.

Drug maker GlaxoSmithKline says second-quarter revenue was 7.3 billion pounds ($9.6 billion), up 4 percent when discounting currency shifts, amid a promising performance of a new shingles treatment.

Anthem Inc. (ANTM) on Wednesday reported second-quarter earnings of $1.05 billion.